Literature DB >> 16188921

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.

C Manichanh1, L Rigottier-Gois, E Bonnaud, K Gloux, E Pelletier, L Frangeul, R Nalin, C Jarrin, P Chardon, P Marteau, J Roca, J Dore.   

Abstract

BACKGROUND AND AIM: A role for the intestinal microbial community (microbiota) in the onset and chronicity of Crohn's disease (CD) is strongly suspected. However, investigation of such a complex ecosystem is difficult, even with culture independent molecular approaches.
METHODS: We used, for the first time, a comprehensive metagenomic approach to investigate the full range of intestinal microbial diversity. We used a fosmid vector to construct two libraries of genomic DNA isolated directly from faecal samples of six healthy donors and six patients with CD. Bacterial diversity was analysed by screening the two DNA libraries, each composed of 25,000 clones, for the 16S rRNA gene by DNA hybridisation.
RESULTS: Among 1190 selected clones, we identified 125 non-redundant ribotypes mainly represented by the phyla Bacteroidetes and Firmicutes. Among the Firmicutes, 43 distinct ribotypes were identified in the healthy microbiota, compared with only 13 in CD (p<0.025). Fluorescent in situ hybridisation directly targeting 16S rRNA in faecal samples analysed individually (n=12) confirmed the significant reduction in the proportion of bacteria belonging to this phylum in CD patients (p<0.02).
CONCLUSION: The metagenomic approach allowed us to detect a reduced complexity of the bacterial phylum Firmicutes as a signature of the faecal microbiota in patients with CD. It also indicated the presence of new bacterial species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188921      PMCID: PMC1856500          DOI: 10.1136/gut.2005.073817

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis.

Authors:  J Castresana
Journal:  Mol Biol Evol       Date:  2000-04       Impact factor: 16.240

2.  The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy.

Authors:  J R Cole; B Chai; T L Marsh; R J Farris; Q Wang; S A Kulam; S Chandra; D M McGarrell; T M Schmidt; G M Garrity; J M Tiedje
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products.

Authors:  Sophie Courtois; Carmela M Cappellano; Maria Ball; Francois-Xavier Francou; Philippe Normand; Gérard Helynck; Asuncion Martinez; Steven J Kolvek; Joern Hopke; Marcia S Osburne; Paul R August; Renaud Nalin; Michel Guérineau; Pascale Jeannin; Pascal Simonet; Jean-Luc Pernodet
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

4.  Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis.

Authors:  J J Godon; E Zumstein; P Dabert; F Habouzit; R Moletta
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Characterization of uncultivated prokaryotes: isolation and analysis of a 40-kilobase-pair genome fragment from a planktonic marine archaeon.

Authors:  J L Stein; T L Marsh; K Y Wu; H Shizuya; E F DeLong
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

7.  Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

Authors:  R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2003-07       Impact factor: 3.287

8.  Molecular inventory of faecal microflora in patients with Crohn's disease.

Authors:  Irène Mangin; Régis Bonnet; Philippe Seksik; Lionel Rigottier-Gois; Malène Sutren; Yoram Bouhnik; Christel Neut; Matthew D Collins; Jean-Frédéric Colombel; Philippe Marteau; Joël Doré
Journal:  FEMS Microbiol Ecol       Date:  2004-10-01       Impact factor: 4.194

9.  Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine.

Authors:  Sylvia H Duncan; Adela Barcenilla; Colin S Stewart; Susan E Pryde; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

10.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

Authors:  W E Moore; L V Holdeman
Journal:  Appl Microbiol       Date:  1974-05
View more
  802 in total

Review 1.  Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?

Authors:  Jot Hui Ooi; Jing Chen; Margherita T Cantorna
Journal:  Mol Aspects Med       Date:  2011-11-06

Review 2.  Immunoregulation by the gut microbiota.

Authors:  Junko Nishio; Kenya Honda
Journal:  Cell Mol Life Sci       Date:  2012-04-22       Impact factor: 9.261

Review 3.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

Review 4.  Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory.

Authors:  W M Dunne; L F Westblade; B Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

5.  Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Authors:  Hideyuki Nemoto; Keiko Kataoka; Hideki Ishikawa; Kazue Ikata; Hideki Arimochi; Teruaki Iwasaki; Yoshinari Ohnishi; Tomomi Kuwahara; Koji Yasutomo
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

6.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 7.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 10.  Placental colonization with periodontal pathogens: the potential missing link.

Authors:  Lori A Fischer; Ellen Demerath; Peter Bittner-Eddy; Massimo Costalonga
Journal:  Am J Obstet Gynecol       Date:  2019-04-30       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.